Remove webcasts
article thumbnail

Helping Manage the Cost of Cancer with a Patient Lens: Opportunities for Pharmacists

Pharmacy Times

This webcast discusses opportunities for pharmacists to address the cost of cancer care and enable improved access and outcomes for patients.

65
article thumbnail

Use of PARP Inhibitors in Breast Cancer: Implications for Pharmacy Practice

Pharmacy Times

The webcast discusses this class of medications and see how they fit into the treatment paradigm for breast cancer. About 1 in 8 women in the United States will develop breast cancer in their lifetime. Overall mortality for breast cancer has decreased over the years with the addition of complex treatment, such as PARP inhibitors.

123
123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Harness the Power of At-Line Spent Media Analysis Using the REBEL to Optimize a CHO mAb Fed-Batch Process

BioPharm

Presented in this webcast are data-driven and accelerated CCM optimization in the Ambr15, leveraging an automated at-line capillary electrophoresis—the REBEL, a mass cell culture spectrometry analyzer- to speed up and optimize CCM and feed strategy optimization.

40
article thumbnail

PureTech to Present at the SVB Securities Global Biopharma Conference

Pharmafile

Published date: 01/02/2023 Summary: PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced that Daphne Zohar, Founder and Chief Executive Officer, and Eric Elenko, Chief Innovation (..)

52
article thumbnail

PureTech to Present at the Barclays Global Healthcare Conference

Pharmafile

A webcast of the presentation will be available at [link] PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced that Bharatt Chowrira, Ph.D., read more

40
article thumbnail

Launching Revvity: a scientific solutions company powering innovation from discovery to cure

European Pharmaceutical Review

Revvity’s Q1 earnings webcast is scheduled on 11 May 2023 at 08:00 ET. What’s ahead? Register here. The Company will trade under its new name and the stock ticker symbol ‘RVTY’ at market open on 16 May 2023. At the same time its 1.875 percent Notes due 2026 will begin trading under ‘RVTY 26.’

81
article thumbnail

Spotlight On The Infectious Diseases Podcast Over 15 Years Old That Just Added New Mobile Streaming Options

IDStewardship

It was the dawn of the online streaming era, and platforms such as YouTube, acquired by Google only a year earlier (2006), were brand new.

Hospitals 151